...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith AGM
2
Aug 22, 2019 06:02PM

Thanks AlbertaClipper. I re-posted as a press release. For future reference, when you post a new message, you can toggle the button to "Press Release" from the default "Message" and it will subsequently show up in the Recent Updates section of the Agoracom Zenith homepage.

BDAZ

3
Aug 22, 2019 08:47PM
Share
New Message
Please login to post a reply